Skip to main content
. 2004 Nov 23;4:83. doi: 10.1186/1471-2407-4-83

Figure 3.

Figure 3

The effect of gefitinib on tumour-derived cells from recurrent ovarian cancer (n = 13). Legend Some tumours show increased sensitivity (lower IndexSUM), while others show enhanced resistance (higher IndexSUM)